Agoracom Blog Home

Posts Tagged ‘$AERO $CBDS $CGRW $APH.ca $GBLX’

Namaste $N.ca Announces Signing of Consulting Agreement With O Cannabis We Stand On Guard For Thee Corporation $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-Eric at 8:20 AM on Tuesday, December 12th, 2017
  • O Cannabis will provide patient consultation services to Namaste’s wholly owned subsidiary, NamasteMD Inc
  • O Cannabis will also be offering a select range of Namaste’s vaporizer hardware in their online platform.

VANCOUVER, British Columbia, Dec. 12, 2017 (GLOBE NEWSWIRE) — Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N)(OTCQB:NXTTF)(FRANKFURT:M5BQ) is pleased to announce that further to its December 5, 2017 announcement: NAMASTE ANNOUNCES NON-BINDING LETTER OF INTENT WITH O CANNABIS CLINIC FOR MANAGEMENT SERVICES, the Company has signed a Services Agreement (the “Agreement”) with O Cannabis We Stand On Guard For Thee Corporation (“O Cannabis”), whereby O Cannabis will provide patient consultation services to Namaste’s wholly owned subsidiary, NamasteMD Inc. (“NamasteMD”). Pursuant to the Agreement, O Cannabis will provide management services to NamasteMD that will include patient consultations, education, strain recommendations and medical document issuance to qualified patients under the guidance of nurse practitioners. In addition to these services, O Cannabis will also be offering a select range of Namaste’s vaporizer hardware in their online platform.

Terms of the Agreement
Under the terms of the Agreement, O Cannabis’ management team will be responsible for the general operation of NamasteMD’s platform and will provide the following services:

  • Patient Qualification
  • Patient Onboarding
  • Education
  • Recommendations (strains and dosages)
  • Follow-up Care
  • Medical Documents
  • Self-titration Training
  • Maintaining 75% patient retention rates

In return for these services, Namaste will pay O Cannabis as follows:

  • CAD $60 for each patient approval, being a patient consultation resulting in the issuance of a prescription for medical cannabis
  • 50% of the net profit for “platinum” packages, as outlined in the Agreement
  • 5% of the gross revenue collected for patients where medical cannabis is sourced from local licensed producers
  • 10% of the gross revenue collected for patients where medical cannabis is sourced from international licensed producers
  • 15% of the gross revenue collected through the sale of Namaste’s vaporizers and cannabis ancillary products, which O Cannabis will add to its website
  • The issuance of 15,000 common share stock options to the O Cannabis management team

Execution of this Agreement represents a major milestone in the expansion of the NamasteMD platform into medical cannabis sales using the Company’s innovative telemedicine application, and will provide an incredibly efficient platform for patient consultations and medical documentation issuance. NamasteMD customers will have the ability to connect to Namaste’s e-commerce platform through Namaste’s wholly owned subsidiary, Cannmart Inc. (“CannMart”), which will provide patients with an online marketplace for medical cannabis products, including strains sourced from both domestic and international licensed producers. CannMart is a late stage applicant for a “Sales Only License” under the Canadian Access to Cannabis for Medical Purposes Regulations (“ACMPR”) program. Namaste’s goal is to become Canada’s leading medical cannabis online retailer by leveraging its existing consumer base, along with utilizing its advanced expertise in e-commerce. In doing so, Namaste believes it can successfully convert and on-board patients at an accelerated growth rate and offer the best quality of care for its patients. Namaste believes that with its aggressive growth strategy and the implementation of NamasteMD, it will be able to accumulate a minimum of 18,200 patients within the first calendar year of operations. This figure is based on Namaste’s current site traffic of 1,000 unique visitors per day with a 5% conversion rate, which would generate 350 patients per week. Namaste expects each patient acquisition to cost on average $60.00 per patient, based on the terms of the Agreement, which is currently lower than any industry standard for medical patients.

About O Cannabis
O Cannabis offers affordable medical cannabis telemedicine appointments to patients across Canada, allowing timely access to quality medicine in remote and under-serviced regions; from Yukon to Newfoundland and everywhere in between. O Cannabis has built a name for themselves by offering unparalleled patient education and industry leading follow up care. O Cannabis patients report their appreciation for the easy and fun telemedicine experience, O Cannabis’ streamlined approach to medical document issuance and the exceptional care patients receive at each step of their medical cannabis journey.

About NamasteMD
NamasteMD is an innovative application that connects patients with medical practitioners through a secure video conference call and incorporates industry-leading facial recognition technology, including instant age and identity verification using data feeds linked to federal databases.  The O Cannabis management team is a highly trained group of medical professionals that offer industry leading care for their patients. Through the NamasteMD platform, patients will be offered a variety of packages that will include both free and paid options. Once a patient receives a medical document, they will have access to purchase directly from CannMart’s medical cannabis marketplace, once CannMart receives its “Sales Only License”. The Company expects the full launch of NamasteMD, including the app for both Apple and Android platforms, to be in operation and accepting patients as soon as December 15, 2017.

Management Commentary
Morgan Toombs, President and CEO of O Cannabis comments: “We are delighted that Namaste has recognized O Cannabis’ expertise within the medical cannabis industry.  Our forte is offering unparalleled education and follow-up care to medical cannabis patients so they can safely navigate the confusing landscape. Our team is honoured to be able to help Namaste’s patient demographic and bring much needed access to qualified Canadians so they can benefit from medical cannabis as a treatment option. We look forward to providing our exceptional care to Namaste’s patients throughout the course of their medical cannabis journey.”

Sean Dollinger, President and CEO of Namaste comments: “We are very proud to be working with such a professional group of people. O Cannabis’ team is dedicated to offering the best possible service and support for patients. This Agreement represents a major milestone for Namaste in launching what we believe to be the most innovative platform for patient acquisitions that the Canadian medical cannabis market has seen. We are looking forward to working with O Cannabis in revolutionizing the way patients connect with doctors and nurse practitioners and will look to create the fastest growing database of patients in the country. Thanks to O Cannabis and their team as well as Namaste’s management team in bringing this opportunity to life. We are very excited about the future!”

About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, US, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]

Further information on the Company and its products can be accessed through the links below:
www.namastetechnologies.com
www.namastevaporizers.com
www.namastevaporizers.co.uk
www.everyonedoesit.com
www.everyonedoesit.co.uk